Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

NSW: Scientists Announce Breakthrough on Herpes




 

Australian Associated Press (08/08/99)

Australian scientists have announced that the drug Valtrex has provided effective, long-term suppression of genital herpes. The antiviral drug is taken in a single daily dose. Valtrex has been shown to substantially reduce the number of genital herpes recurrences in patients. Herpes affects over 102 million people worldwide, and 500,000 cases have been diagnosed in Australia, according to Dr. Tony Simmons, chairman of the Australian Herpes Management Forum.



 


Copyright © 1999 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in August 9, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.